Platelet-rich plasma effects in an in vitro donkey endometritis model

Viewing 0 reply threads
  • Author
    Posts
    • #22850

      Platelet-rich plasma exhibits antibacterial and anti-inflammatory effects in an in vitro donkey endometritis model

      Equine Vet J. 2026 Oct 4. doi: 10.1002/evj.70342. Online ahead of print.
      Authors
      Yun Ling 1 , Xin’er Lan 1 , Shiyu Duan 1 , Jie Yu 2 3 , Jinni Sun 2 3 , Honglei Qu 2 3 , Teng Lu 2 3 , Zixuan Wang 1 4 , Yiping Zhu 1 4 , Jing Li 1 4
      Affiliations

      1 Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
      2 National Engineering Research Center for Gelatin-Based Traditional Chinese Medicine, Shandong, China.
      3 Dong-E E-Jiao Co. Ltd., Shandong, China.
      4 State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

      PMID: 42830113
      DOI: 10.1002/evj.70342

      Abstract

      Background: Infectious endometritis, mainly caused by Escherichia coli (E. coli) and Streptococcus equi subsp. zooepidemicus (SEZ), significantly impairs donkey reproductive performance. Platelet-rich plasma (PRP) shows promise as an anti-inflammatory and antibiotic alternative.

      Objectives: To evaluate PRP’s antimicrobial efficacy against key pathogens and assess its anti-inflammatory and tissue repair properties in an in vitro endometrial model.

      Study design: Non-randomised in vitro and explant experiments.

      Methods: In in vitro antibacterial assays, the inhibitory effects of PRP on the growth of E. coli and SEZ were evaluated. In an in vitro infected endometrial explant model, tissues were treated with PRP, ceftiofur (CEF), 1/2 MIC CEF, or PRP combined with 1/2 MIC CEF. Antibacterial efficacy was evaluated by bacterial load quantification, while inflammatory and healing responses were assessed by measuring the protein levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), anti-inflammatory cytokine (IL-10), tissue repair factor (TGF-β), matrix metallopeptidase 9 (MMP-9), and histological examination of the endometrium.

      Results: 50% PRP significantly inhibited E. coli and SEZ during an 8 h culture period (p < 0.05), although efficacy decreased by 24 h. In the SEZ model, PRP reduced bacterial load, IL-1β, IL-6, TNF-α, and TGF-β levels while enhancing the expression of IL-10 and MMP-9 (p < 0.05). In the E. coli model, PRP + 1/2 MIC CEF demonstrated synergistic antibacterial and optimal anti-inflammatory effects (p < 0.05). PRP also promoted epithelial and glandular repair as indicated by upregulated MMP-9 levels. Main limitations: Models may not fully replicate complex co-infections and cell interactions. Conclusion: The antibacterial efficacy of PRP depends on concentration, duration, and pathogen type, with PRP showing greater inhibitory effects against SEZ than E. coli. Application strategies should be tailored to the type of infectious endometritis to maximise the effect of PRP. Keywords: bacteriostatic effect; donkey; horse; infectious endometritis; inflammatory regulation; platelet‐rich plasma. © 2026 EVJ Ltd.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.